Recent Advances in β-lactam Derivatives as Potential Anticancer Agents

Area of Science:

• Medicinal Chemistry
• Oncology
• Drug Discovery

Background:

• Cancer is a leading global cause of death, with drug resistance and low specificity of current agents posing significant challenges.
• Developing novel anticancer agents with improved efficacy and specificity is imperative for cancer treatment.
• Beta-lactam derivatives are recognized for their diverse pharmacological properties and potential as versatile scaffolds in drug discovery.

Purpose of the Study:

• To provide a comprehensive overview of beta-lactam derivatives as potential anticancer agents.
• To cover research published between 2000 and 2020 on beta-lactam derivatives for cancer therapy.
• To discuss mechanisms of action, design principles, and structure-activity relationships of these compounds.

Main Methods:

• Literature review of scientific articles published from 2000 to 2020.
• Analysis of studies focusing on beta-lactam derivatives with anticancer activity.
• Synthesis and evaluation of structure-activity relationships (SAR) for beta-lactam compounds.

Main Results:

• Beta-lactam derivatives demonstrate significant potency against both drug-sensitive and drug-resistant cancer cell lines.
• Various beta-lactam structures have been identified as promising lead compounds for anticancer drug development.
• Structure-activity relationship studies provide insights into optimizing beta-lactam scaffolds for enhanced anticancer efficacy.

Conclusions:

• Beta-lactam derivatives represent a valuable and versatile scaffold for the development of novel anticancer agents.
• These compounds hold therapeutic potential for various cancers, including drug-resistant types.
• Further research into beta-lactam derivatives could lead to more effective cancer chemotherapies.